These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 39090761

  • 1. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W, Xiao G, Xie G, Chen Z, Xu X, Zeng J, Xie J.
    Thorac Cancer; 2024 Sep; 15(26):1871-1881. PubMed ID: 39090761
    [Abstract] [Full Text] [Related]

  • 2. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1.
    Song D, Wang Q, Yan Z, Su M, Zhang H, Shi L, Fan Y, Zhang Q, Yang H, Zhang D, Liu Q.
    Biol Direct; 2024 Jun 07; 19(1):44. PubMed ID: 38849910
    [Abstract] [Full Text] [Related]

  • 3. METTL3 and IGF2BP1-Mediated m6A Modification of ZHX2 Promotes Tumor Property of Renal Cell Carcinoma.
    Xiao B, Li Y, Yang Y, Chen C, Gong S, Li H, Yao Q, Wang L.
    Kidney Blood Press Res; 2024 Jun 07; 49(1):787-798. PubMed ID: 39159608
    [Abstract] [Full Text] [Related]

  • 4. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
    Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, Pan L, Su G.
    J Hematol Oncol; 2019 Dec 09; 12(1):135. PubMed ID: 31818312
    [Abstract] [Full Text] [Related]

  • 5. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C, Ren Q, Deng J, Wang S, Ren L.
    Biomed J; 2024 Aug 09; 47(4):100664. PubMed ID: 37774794
    [Abstract] [Full Text] [Related]

  • 6. Cancer-associated fibroblasts-derived exosomal METTL3 promotes the proliferation, invasion, stemness and glutaminolysis in non-small cell lung cancer cells by eliciting SLC7A5 m6A modification.
    Fan Y, Yu Y.
    Hum Cell; 2024 Jul 09; 37(4):1120-1131. PubMed ID: 38625505
    [Abstract] [Full Text] [Related]

  • 7. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S, Lu X, Zheng D, Chen W, Li Y, Li F.
    J Cancer Res Clin Oncol; 2022 Dec 09; 148(12):3485-3499. PubMed ID: 35907010
    [Abstract] [Full Text] [Related]

  • 8. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
    Li D, Fu Z, Dong C, Song Y.
    Bioengineered; 2022 Apr 09; 13(4):10493-10503. PubMed ID: 35441574
    [Abstract] [Full Text] [Related]

  • 9. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X, Wang Z, Lu W, Miao L, Zhao Y.
    BMC Pulm Med; 2022 Aug 25; 22(1):324. PubMed ID: 36008805
    [Abstract] [Full Text] [Related]

  • 10. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J, Xie H, Ying Y, Chen H, Yan H, He L, Xu M, Xu X, Liang Z, Liu B, Wang X, Zheng X, Xie L.
    Mol Cancer; 2020 Oct 29; 19(1):152. PubMed ID: 33121495
    [Abstract] [Full Text] [Related]

  • 11. TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response.
    Wang Y, Zhang Y, Ouyang J, Yi H, Wang S, Liu D, Dai Y, Song K, Pei W, Hong Z, Chen L, Zhang W, Liu Z, Mcleod HL, He Y.
    Cell Oncol (Dordr); 2024 Jun 29; 47(3):779-791. PubMed ID: 37902941
    [Abstract] [Full Text] [Related]

  • 12. METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth.
    Wu S, Wang H, Yang Q, Liu Z, Du J, Wang L, Chen S, Lu Q, Yang DH.
    Cancer Lett; 2024 Aug 10; 597():217058. PubMed ID: 38880226
    [Abstract] [Full Text] [Related]

  • 13. METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression.
    He G, Gu K, Wei J, Zhang J.
    Thorac Cancer; 2024 Apr 10; 15(11):919-928. PubMed ID: 38462740
    [Abstract] [Full Text] [Related]

  • 14. Berberine inhibits the progression of breast cancer by regulating METTL3-mediated m6A modification of FGF7 mRNA.
    Fu W, Liu L, Tong S.
    Thorac Cancer; 2024 Jun 10; 15(17):1357-1368. PubMed ID: 38709912
    [Abstract] [Full Text] [Related]

  • 15. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
    Zhang Y, Liu S, Zhao T, Dang C.
    Oncol Rep; 2021 Aug 10; 46(2):. PubMed ID: 34132367
    [Abstract] [Full Text] [Related]

  • 16. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
    He P, Liu X, Yu G, Wang Y, Wang S, Liu J, An Y.
    Mol Cell Biochem; 2024 Jul 10; 479(7):1707-1720. PubMed ID: 38822192
    [Abstract] [Full Text] [Related]

  • 17. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM, Qi FF, Wang J, Duan YY, Zhao LL, Wang YD, Zhang TC, Liao XH.
    Int J Mol Sci; 2022 Jun 09; 23(12):. PubMed ID: 35742899
    [Abstract] [Full Text] [Related]

  • 18. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
    Yi J, Peng F, Zhao J, Gong X.
    Sci Rep; 2023 Oct 12; 13(1):17292. PubMed ID: 37828232
    [Abstract] [Full Text] [Related]

  • 19. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression.
    Hua M, Zhai X, Chen Y, Yin D.
    Pathol Res Pract; 2024 Aug 12; 260():155437. PubMed ID: 38959625
    [Abstract] [Full Text] [Related]

  • 20. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, Zhao G.
    Mol Cancer; 2019 Oct 13; 18(1):142. PubMed ID: 31607270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.